Syndax Pharmaceuticals Inc (SNDX)
20.30
-0.62
(-2.96%)
USD |
NASDAQ |
May 17, 16:00
20.30
0.00 (0.00%)
After-Hours: 20:00
Syndax Pharmaceuticals Price to Book Value: 3.506 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 3.506 |
| May 16, 2024 | 3.614 |
| May 15, 2024 | 3.791 |
| May 14, 2024 | 3.742 |
| May 13, 2024 | 3.623 |
| May 10, 2024 | 3.758 |
| May 09, 2024 | 3.796 |
| May 08, 2024 | 3.867 |
| May 07, 2024 | 4.005 |
| May 06, 2024 | 3.888 |
| May 03, 2024 | 3.810 |
| May 02, 2024 | 3.777 |
| May 01, 2024 | 3.796 |
| April 30, 2024 | 3.650 |
| April 29, 2024 | 3.676 |
| April 26, 2024 | 3.638 |
| April 25, 2024 | 3.554 |
| April 24, 2024 | 3.592 |
| April 23, 2024 | 3.623 |
| April 22, 2024 | 3.621 |
| April 19, 2024 | 3.593 |
| April 18, 2024 | 3.540 |
| April 17, 2024 | 3.583 |
| April 16, 2024 | 3.676 |
| April 15, 2024 | 3.735 |
| Date | Value |
|---|---|
| April 12, 2024 | 3.752 |
| April 11, 2024 | 3.856 |
| April 10, 2024 | 3.802 |
| April 09, 2024 | 3.974 |
| April 08, 2024 | 3.941 |
| April 05, 2024 | 3.954 |
| April 04, 2024 | 3.908 |
| April 03, 2024 | 4.11 |
| April 02, 2024 | 4.024 |
| April 01, 2024 | 4.108 |
| March 28, 2024 | 3.650 |
| March 27, 2024 | 3.538 |
| March 26, 2024 | 3.288 |
| March 25, 2024 | 3.441 |
| March 22, 2024 | 3.462 |
| March 21, 2024 | 3.508 |
| March 20, 2024 | 3.531 |
| March 19, 2024 | 3.407 |
| March 18, 2024 | 3.361 |
| March 15, 2024 | 3.606 |
| March 14, 2024 | 3.473 |
| March 13, 2024 | 3.643 |
| March 12, 2024 | 3.658 |
| March 11, 2024 | 3.614 |
| March 08, 2024 | 3.767 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.998
Minimum
Feb 14 2022
14.15
Maximum
May 15 2020
4.364
Average
3.844
Median
Aug 25 2021
Price to Book Value Benchmarks
| Geron Corp | 6.553 |
| Verastem Inc | 11.62 |
| Karyopharm Therapeutics Inc | -- |
| Crinetics Pharmaceuticals Inc | 4.633 |
| Arvinas Inc | 3.668 |
Price to Book Value Related Metrics
| PS Ratio | 10.79 |
| Price | 20.30 |
| Earnings Yield | -15.87% |
| Market Cap | 1.724B |
| Operating PE Ratio | 57.51 |
| Normalized PE Ratio | 47.19 |